Cerus Corporation CERS-Financial and Strategic SWOT Analysis Review

Cerus Corporation CERS-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH26394FSA
  • |
  • Pages: 60
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Cerus Corporation (CERS)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cerus Corporation (Cerus) is a biomedical products manufacturing company which develops and commercializes Intercept Blood System for blood safety. The company has rights of Intercept for three blood components, namely, platelets, red blood cells and plasma. The system is designed to target and inactivate blood-borne pathogens, such as viruses, bacteria, and parasites, as well as harmful white blood cells (WBC) included in donated blood components intended for transfusion. It markets its product in the US, Europe, Russia, the Middle East and selected countries of other regions of the world for the treatment of both platelets and plasma for transfusions and it is also being developed for the treatment of red blood cells. Cerus is headquartered in Concord, California, the US.

Cerus Corporation Key Recent Developments

Mar 08, 2016: Cerus Reports Fourth Quarter and Year End 2015 Results

Jan 11, 2016: Cerus Appoints New Leadership for Europe, Middle East and Africa Region

Jan 05, 2016: Cerus Announces Agreement with Blood Systems for the Use of INTERCEPT Platelets and Plasma

Dec 10, 2015: Cerus Announces Agreement with the National Transfusiology Center of Mongolia for the Use of INTERCEPT Platelets and Plasma

Dec 01, 2015: Cerus and The Community Blood Center Enter into Agreement for the Use of INTERCEPT Platelets and Plasma

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

Cerus Corporation-Key Facts 6

Cerus Corporation-Key Employees 7

Cerus Corporation-Key Employee Biographies 8

Cerus Corporation-Major Products and Services 9

Cerus Corporation-History 10

Cerus Corporation-Company Statement 17

Cerus Corporation-Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Section 2-Company Analysis 26

Cerus Corporation-Business Description 26

Cerus Corporation-Corporate Strategy 27

Cerus Corporation-SWOT Analysis 28

SWOT Analysis-Overview 28

Cerus Corporation-Strengths 28

Strength-Robust Intellectual Property Portfolio 28

Strength-Strategic Partnerships 28

Strength-The INTERCEPT Blood System Technology 28

Cerus Corporation-Weaknesses 29

Weakness-History of Losses 29

Weakness-Concentration of Customers 29

Cerus Corporation-Opportunities 30

Opportunity-Product Approvals 30

Opportunity-CE Label Expands Compatibility 30

Opportunity-Strategic Agreements 30

Opportunity-Strategic Partnerships 30

Cerus Corporation-Threats 31

Threat-Lack of Manufacturing Facility 31

Threat-Safety Paradigm 31

Threat-Competitive Environment 31

Cerus Corporation-Key Competitors 32

Section 3-Company Financial Ratios 33

Financial Ratios-Capital Market Ratios 33

Financial Ratios-Annual Ratios 34

Performance Chart 35

Financial Performance 35

Financial Ratios-Interim Ratios 36

Financial Ratios-Ratio Charts 37

Section 4-Company's Lifesciences Financial Deals and Alliances 38

Cerus Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016 38

Cerus Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016 39

Cerus Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 40

Cerus Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 41

Cerus Corporation, Recent Deals Summary 42

Section 5-Company's Recent Developments 43

Mar 08, 2016: Cerus Reports Fourth Quarter and Year End 2015 Results 43

Jan 11, 2016: Cerus Appoints New Leadership for Europe, Middle East and Africa Region 45

Jan 05, 2016: Cerus Announces Agreement with Blood Systems for the Use of INTERCEPT Platelets and Plasma 46

Dec 10, 2015: Cerus Announces Agreement with the National Transfusiology Center of Mongolia for the Use of INTERCEPT Platelets and Plasma 47

Dec 01, 2015: Cerus and The Community Blood Center Enter into Agreement for the Use of INTERCEPT Platelets and Plasma 48

Nov 05, 2015: Cerus Reports Third Quarter 2015 Results 49

Oct 21, 2015: Cerus Announces New Agreement With Fresenius Kabi for the Production of INTERCEPT Blood System Kits 51

Aug 06, 2015: Cerus Reports Second Quarter 2015 Results 52

Jul 13, 2015: Cerus and Bonfils Blood Center Enter Into Agreement for the Use of INTERCEPT Platelets and Plasma 54

Jun 08, 2015: Richard J. Benjamin, MD PhD Appointed as Cerus Corporation's New Chief Medical Officer 55

Section 6-Appendix 56

Methodology 56

Ratio Definitions 56

About GlobalData 60

Contact Us 60

Disclaimer 60

List of Figures

Cerus Corporation, Performance Chart (2011-2015) 35

Cerus Corporation, Ratio Charts 37

Cerus Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016 38

Cerus Corporation, Medical Equipment, Deals by Type, 2010 to YTD 2016 39

Cerus Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 40

Cerus Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 41

List of Tables

Cerus Corporation, Key Facts 6

Cerus Corporation, Key Employees 7

Cerus Corporation, Key Employee Biographies 8

Cerus Corporation, Major Products and Services 9

Cerus Corporation, History 10

Cerus Corporation, Subsidiaries 25

Cerus Corporation, Key Competitors 32

Cerus Corporation, Ratios based on current share price 33

Cerus Corporation, Annual Ratios 34

Cerus Corporation, Interim Ratios 36

Cerus Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016 38

Cerus Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016 39

Cerus Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 40

Cerus Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 41

Cerus Corporation, Recent Deals Summary 42

Currency Codes 56

Capital Market Ratios 56

Equity Ratios 57

Profitability Ratios 57

Cost Ratios 58

Liquidity Ratios 58

Leverage Ratios 59

Efficiency Ratios 59

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Cerus Corporation, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 125 INR 8033
Site License
USD 250 INR 16065
Corporate User License
USD 375 INR 24098

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com